Industries > Pharma > Global Drug-Device Combination Market 2017-2027

Global Drug-Device Combination Market 2017-2027

Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings

PUBLISHED: 30 August 2017
PAGES: 151
PRODUCT CODE: PHA0230

Clear
WOOCS 2.2.1

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Drug-Device Combination Market forecasts from 2017-2027

• Revenue forecast for the drug-device combination market by End-Users:
– Hospitals & clinics
– Emergency service centers
– Ambulatory surgical centers
– Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• Revenue forecast for the drug-device combination market by Products:
– Drug eluting stents
– Photosensitizers
– Orthopaedic products
– Infusion pumps
– Wound care products
– Transmucosal products
– Transdermal patches
– Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
North America: The U.S and Rest of North America
Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
– Rest of the world (RoW): Latin America, and Middle East and African countries

Global Drug-Device Combination Market 2017-2027

Each regional market is further divided by end-users and products

• This report discusses the leading companies in the global drug-device combination market:
– Medtronic
– Boston Scientific Corporation
– Stryker Corporation
– Ethicon Inc
– C.R. Bard Inc.
– Medline Industries Inc.
– Mylan Inc.
– Terumo Corporation
– Pinnacle Biologics Inc.
– W. L. Gore & Associates, Inc.

• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug-device combination market

Visiongain’s study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories